Publication | Closed Access

Risk factors and clinical outcomes of Epstein–Barr virus DNAemia and post-transplant lymphoproliferative disorders after haploidentical and matched-sibling PBSCT in patients with hematologic malignancies

TransplantationBone Marrow FailureImmunodeficienciesHematologyTransplantation MedicinePathologyImmunologyClinical OutcomesMedicineCell TransplantationRisk FactorsEpstein–barr Virus DnaemiaHealth Sciences